We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNAGR
276
DELISTED
99 Acquisition Group Inc Right
NNAGR
$51.7K ﹤0.01%
+344,518
New +$60.9K
ECDAW
277
DELISTED
ECD Automotive Design Warrant
ECDAW
$50.2K ﹤0.01%
1,255,150
+1,155,003
+1,153% +$35.2K
PGSS.WS
278
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$49.9K ﹤0.01%
622,963
+442,963
+246% +$34.1K
YOTAR
279
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$48.8K ﹤0.01%
406,577
-14,078
-3% -$1.47K
ADVWW
280
DELISTED
Advantage Solutions Warrant
ADVWW
$48.7K ﹤0.01%
535,993
+64,027
+14% +$8.92K
DBVT
281
DBV Technologies
DBVT
$888M
$48.6K ﹤0.01%
+5,099
New +$49.4K
ATAKR
282
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$48K ﹤0.01%
259,362
+153,398
+145% +$24.2K
AMBP.WS
283
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$46.3K ﹤0.01%
462,500
+229,845
+99% +$19.4K
ASCBR
284
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$45.9K ﹤0.01%
510,521
+226,821
+80% +$22.3K
ALCE
285
DELISTED
Alternus Clean Energy Inc
ALCE
$45K ﹤0.01%
1,200
-3,139
-72% -$658K
AMBI.WS
286
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
$44.4K ﹤0.01%
113,104
+11,365
+11% +$4.51K
AQUNR
287
DELISTED
Aquaron Acquisition Corp. Rights
AQUNR
$44.4K ﹤0.01%
246,407
+64,200
+35% +$16.3K
GDEVW icon
288
GDEV Inc Warrant
GDEVW
$30.4K
$44.2K ﹤0.01%
700,383
-9,200
-1% -$1.14K
SEATW icon
289
Vivid Seats Inc Warrant
SEATW
$510K
$44K ﹤0.01%
43,594
-300
-0.7% -$379
GLACR
290
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$42.5K ﹤0.01%
+265,937
New +$51.2K
HCVIW
291
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$40.8K ﹤0.01%
668,377
+587,777
+729% +$49.7K
BNIXR
292
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$40.3K ﹤0.01%
149,365
+500
+0.3% +$126
IVCPW
293
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$40.2K ﹤0.01%
935,935
-10,897
-1% -$604
SST.WS
294
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$40K ﹤0.01%
+250,000
New +$22.2K
GB.WS
295
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$39.4K ﹤0.01%
563,497
+349,607
+163% +$64.6K
TMTCR
296
DELISTED
TMT Acquisition Corp Rights
TMTCR
$39.2K ﹤0.01%
180,023
-49,401
-22% -$12.1K
PL icon
297
Planet Labs
PL
$8.39B
$38.9K ﹤0.01%
15,749
– –
SOAR.WS
298
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$38.8K ﹤0.01%
348,950
+265,150
+316% +$24.7K
NIOBW
299
NioCorp Developments Ltd Warrant
NIOBW
$80.2M
$38.7K ﹤0.01%
73,000
-10,703
-13% -$5.26K
EVTL.WS
300
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$38.5K ﹤0.01%
678,254
+468,904
+224% +$25.6K
10 11
12
13 14

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.